{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Disomie uniparentale : Questions médicales les plus fréquentes",
"headline": "Disomie uniparentale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Disomie uniparentale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Disomie uniparentale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aberrations des chromosomes",
"url": "https://questionsmedicales.fr/mesh/D002869",
"about": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes",
"code": {
"@type": "MedicalCode",
"code": "D002869",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Disomie uniparentale",
"alternateName": "Uniparental Disomy",
"code": {
"@type": "MedicalCode",
"code": "D024182",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Musaffe Tuna",
"url": "https://questionsmedicales.fr/author/Musaffe%20Tuna",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Baylor College of Medicine, One Baylor Plaza room 100.23D, Houston, TX 77030, USA. Electronic address: mtuna9@gmail.com."
}
},
{
"@type": "Person",
"name": "Christopher I Amos",
"url": "https://questionsmedicales.fr/author/Christopher%20I%20Amos",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Baylor College of Medicine, One Baylor Plaza room 100.23D, Houston, TX 77030, USA; Institute of Clinical and Translational Medicine, Baylor College of Medicine, USA."
}
},
{
"@type": "Person",
"name": "Gordon B Mills",
"url": "https://questionsmedicales.fr/author/Gordon%20B%20Mills",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell, Developmental & Cancer Biology, School of Medicine, Oregon Health Science University, Portland, OR, USA; Precision Oncology, Knight Cancer Institute, Portland, OR, USA."
}
},
{
"@type": "Person",
"name": "Chih-Ping Chen",
"url": "https://questionsmedicales.fr/author/Chih-Ping%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan; Department of Biotechnology, Asia University, Taichung, Taiwan; School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Institute of Clinical and Community Health Nursing, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Obstetrics and Gynecology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan."
}
},
{
"@type": "Person",
"name": "Thomas Eggermann",
"url": "https://questionsmedicales.fr/author/Thomas%20Eggermann",
"affiliation": {
"@type": "Organization",
"name": "Institute of Human Genetics and Genomic Medicine, Aachen University, Aachen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36807581",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jafc.2c07264"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37354314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43440-023-00508-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37021557",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jsfa.12608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37070956",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.molpharmaceut.2c01117"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.",
"datePublished": "2023-01-25",
"url": "https://questionsmedicales.fr/article/36504232",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2em00396a"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Variation génétique",
"item": "https://questionsmedicales.fr/mesh/D014644"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mutation",
"item": "https://questionsmedicales.fr/mesh/D009154"
},
{
"@type": "ListItem",
"position": 5,
"name": "Aberrations des chromosomes",
"item": "https://questionsmedicales.fr/mesh/D002869"
},
{
"@type": "ListItem",
"position": 6,
"name": "Disomie uniparentale",
"item": "https://questionsmedicales.fr/mesh/D024182"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Disomie uniparentale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Disomie uniparentale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Disomie uniparentale",
"description": "Comment diagnostiquer la disomie uniparentale ?\nQuels tests sont utilisés pour la disomie uniparentale ?\nQuels signes cliniques indiquent une disomie uniparentale ?\nLa disomie uniparentale est-elle héréditaire ?\nQuel rôle joue le conseil génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D024182?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Disomie uniparentale",
"description": "Quels sont les symptômes courants de la disomie uniparentale ?\nLa disomie uniparentale cause-t-elle des troubles mentaux ?\nY a-t-il des symptômes spécifiques selon le chromosome affecté ?\nLes symptômes apparaissent-ils dès la naissance ?\nLa disomie uniparentale affecte-t-elle la croissance physique ?",
"url": "https://questionsmedicales.fr/mesh/D024182?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Disomie uniparentale",
"description": "Peut-on prévenir la disomie uniparentale ?\nLe dépistage prénatal peut-il détecter la disomie uniparentale ?\nLes antécédents familiaux influencent-ils le risque ?\nLes tests génétiques avant la grossesse sont-ils recommandés ?\nLes conseils préconceptionnels sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D024182?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Disomie uniparentale",
"description": "Quels traitements sont disponibles pour la disomie uniparentale ?\nLa disomie uniparentale nécessite-t-elle une intervention chirurgicale ?\nLes médicaments sont-ils efficaces pour traiter cette condition ?\nComment la thérapie comportementale aide-t-elle ?\nY a-t-il des traitements expérimentaux pour la disomie uniparentale ?",
"url": "https://questionsmedicales.fr/mesh/D024182?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Disomie uniparentale",
"description": "Quelles complications peuvent survenir avec la disomie uniparentale ?\nLa disomie uniparentale augmente-t-elle le risque de maladies ?\nY a-t-il des risques de complications à long terme ?\nLes complications varient-elles selon le chromosome affecté ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D024182?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Disomie uniparentale",
"description": "Quels sont les facteurs de risque de la disomie uniparentale ?\nLes traitements de fertilité augmentent-ils le risque ?\nY a-t-il des facteurs environnementaux impliqués ?\nLes anomalies chromosomiques augmentent-elles le risque ?\nLes antécédents de fausses couches sont-ils un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D024182?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la disomie uniparentale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par analyse génétique, souvent via un test d'ADN."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la disomie uniparentale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de microsatellite et le séquençage de l'ADN sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une disomie uniparentale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de croissance ou des troubles métaboliques peuvent indiquer cette condition."
}
},
{
"@type": "Question",
"name": "La disomie uniparentale est-elle héréditaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être héritée, mais souvent elle résulte d'une erreur lors de la formation des gamètes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à comprendre les risques et les implications de la disomie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la disomie uniparentale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des retards de développement et des anomalies congénitales."
}
},
{
"@type": "Question",
"name": "La disomie uniparentale cause-t-elle des troubles mentaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être associée à des troubles du développement intellectuel dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques selon le chromosome affecté ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes varient selon le chromosome impliqué, comme le chromosome 15."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils dès la naissance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent être présents à la naissance, d'autres se développent plus tard."
}
},
{
"@type": "Question",
"name": "La disomie uniparentale affecte-t-elle la croissance physique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des problèmes de croissance et des anomalies physiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la disomie uniparentale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention, mais le conseil génétique peut aider à évaluer les risques."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal peut-il détecter la disomie uniparentale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage prénatal peut identifier certains risques, mais pas toujours la disomie."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles génétiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les tests génétiques avant la grossesse sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être recommandés pour les couples à risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les conseils préconceptionnels sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à identifier les risques génétiques avant la conception."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la disomie uniparentale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes et peut inclure des thérapies physiques ou comportementales."
}
},
{
"@type": "Question",
"name": "La disomie uniparentale nécessite-t-elle une intervention chirurgicale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale peut être nécessaire pour corriger certaines anomalies physiques."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils efficaces pour traiter cette condition ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de médicaments spécifiques, mais des traitements symptomatiques peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment la thérapie comportementale aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut améliorer les compétences sociales et comportementales des individus affectés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour la disomie uniparentale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des thérapies géniques, mais elles ne sont pas encore disponibles."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la disomie uniparentale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de croissance, des problèmes métaboliques et des malformations."
}
},
{
"@type": "Question",
"name": "La disomie uniparentale augmente-t-elle le risque de maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut augmenter le risque de certaines maladies génétiques et métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des retards de développement et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le chromosome affecté ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier en fonction du chromosome impliqué dans la disomie."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des soins médicaux adaptés et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la disomie uniparentale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge parental avancé et des antécédents familiaux de troubles génétiques."
}
},
{
"@type": "Question",
"name": "Les traitements de fertilité augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements de fertilité peuvent augmenter le risque de disomie uniparentale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux impliqués ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux peuvent influencer le risque, mais leur rôle n'est pas bien compris."
}
},
{
"@type": "Question",
"name": "Les anomalies chromosomiques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies chromosomiques dans la famille peuvent augmenter le risque de disomie."
}
},
{
"@type": "Question",
"name": "Les antécédents de fausses couches sont-ils un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de fausses couches peuvent être associés à un risque accru de disomie."
}
}
]
}
]
}
Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...
Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp...
The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,...
The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ...
The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....
Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi...
The MIA-QSAR models based on van der Waals radii (r...
Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...
Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...
Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...
Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p...
To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum....
The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ...
The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru...
Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...
Currently, increasing availability and popularity of designer benzodiazepines (DBZDs) constitutes a primary threat to public health. To assess this threat, the biological activity/potency of DBZDs was...
3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...
The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...
A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...